198 related articles for article (PubMed ID: 26039918)
1. [Frequency of T-cell mediated rejection in new-onset diabetes after kidney transplantation].
Borda B; Szederkényi E; Lengyel C; Várkonyi T; Hódi Z; Kemény É; Szabó V; Lázár G
Orv Hetil; 2015 May; 156(19):785-9. PubMed ID: 26039918
[TBL] [Abstract][Full Text] [Related]
2. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
[TBL] [Abstract][Full Text] [Related]
3. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
Chadban S
Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
[No Abstract] [Full Text] [Related]
4. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
6. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
Hoitsma AJ; Hilbrands LB
Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
[TBL] [Abstract][Full Text] [Related]
7. Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.
Ghisdal L; Bouchta NB; Broeders N; Crenier L; Hoang AD; Abramowicz D; Wissing KM
Transpl Int; 2008 Feb; 21(2):146-51. PubMed ID: 17971033
[TBL] [Abstract][Full Text] [Related]
8. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
9. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
[TBL] [Abstract][Full Text] [Related]
10. New-Onset Diabetes After Transplantation: Comparison Between a Cyclosporine-Based and a Tacrolimus-Based Immunosuppressive Regimen.
Zolota A; Miserlis G; Solonaki F; Tranda A; Antoniadis N; Imvrios G; Fouzas I
Transplant Proc; 2018 Dec; 50(10):3386-3391. PubMed ID: 30577210
[TBL] [Abstract][Full Text] [Related]
11. Early histopathological changes in new-onset diabetes after kidney transplantation.
Borda B; Munir Ibrahim Y; Lengyel C; Várkonyi T; Kubik A; Keresztes C; Lázár G
Transplant Proc; 2014; 46(6):2155-9. PubMed ID: 25131129
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
[TBL] [Abstract][Full Text] [Related]
14. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
15. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[TBL] [Abstract][Full Text] [Related]
16. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.
Marin M; Renoult E; Bondor CI; Kessler M
Transplant Proc; 2005 May; 37(4):1851-6. PubMed ID: 15919484
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
Choi JY; Kwon OJ
Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
